Quick Answer
Wave Life Sciences Ltd. reported Stockholders Equity of $518.36 million for fiscal year 2025.
Wave Life Sciences Ltd. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $518.36M | +147.4% |
| 2024 | $209.51M | +428.7% |
| 2023 | $39.63M | +187.9% |
| 2022 | -$45.09M | -238.8% |
| 2021 | $32.50M | -60.7% |
| 2020 | $82.78M | +29.9% |
| 2019 | $63.73M | -13.1% |
| 2018 | $73.35M | -47.5% |
| 2017 | $139.61M | +3.7% |
| 2016 | $134.60M | -12.3% |
| 2015 | $153.49M | +7472.3% |
| 2014 | $2.03M | +126.1% |
| 2013 | -$7.76M | -69.5% |
| 2012 | -$4.58M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $124.55M | -12.1% | -10.6% |
| June 30, 2025 | $139.27M | +4105.3% | -18.9% |
| March 31, 2025 | $171.80M | +576.7% | -18.0% |
| December 31, 2024 | $209.51M | +428.7% | +47.9% |
| September 30, 2024 | $141.64M | +449.8% | +4173.6% |
| June 30, 2024 | -$3.48M | +93.3% | -113.7% |
| March 31, 2024 | $25.39M | +173.1% | -35.9% |
| December 31, 2023 | $39.63M | +187.9% | +197.9% |
- Wave Life Sciences Ltd. showed an increase of +147.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, Wave Life Sciences Ltd.’s stockholders equity has grown by 11420.3% (from -$4.58 million to $518.36 million).
- The most recent figure is from Wave Life Sciences Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: